The internal generative AI platform is designed to support faster ideation, asset creation and hyper-personalised brand outputs while keeping creative teams at the centre of the process
A strategic investor is in advanced negotiations to acquire cancer diagnostics company Exact Sciences (EXAS), a development that propelled its stock price to close...